Feasibility of a Digital Therapeutic for Adults With Binge Eating and Obesity
Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18-70
SponsorOui Therapeutics, Inc.
About this trial
The primary objective of this study is to test the feasibility of a digital therapeutic to address comorbid binge eating and obesity in adults.
Eligibility criteria
Qualifiers
English speaking male or female patients, 18-70 years
Patients with recurrent binge eating (≥12 episodes in 3 months) and obesity (BMI ≥30)
Understand written and spoken English
Own an iPhone with iOS 11 or higher, or Android with OS 8.1 or higher
Disqualifiers
Patients with active psychosis
Patients who are acutely intoxicated at the time of enrollment
Currently enrolled in other treatment studies for the symptoms and behaviors targeted
Patients who are cognitively impaired
Trial design
Treatments tested in this trial
- OTX-401
Treatment groups
30 Participants
are divided into 1 treatment groupLocations
Sponsors and collaborators
Oui Therapeutics, Inc.
Lead sponsor
National Institute of Mental Health (NIMH)
Collaborator
Source ClinicalTrials.gov